Warning Warning: I am able to write to the configuration file: /home/ebinfo/public_html/includes/configure.php. This is a potential security risk - please set the right user permissions on this file (read-only, CHMOD 644 or 444 are typical). You may need to use your webhost control panel/file-manager to change the permissions effectively. Contact your webhost for assistance. See this FAQ

Nandrolone Phenylpropionate


Item Name- Price
Durabolin 100 mg - Durabol Inject by British Dragon

Durabolin 100 mg - Durabol Inject by British Dragon

Durabolin - Durabol Inject by British Dragon ONE ORDER UNIT INCLUDES: 10 ml vial containing 1000 mg 1 ml CONTAINS: 100 mg/ml TOTAL ml PER ONE ORDER...
EUR 74.00



Durabolin 100 mg - Durobolic Injection by Asia Pharma

Durabolin 100 mg - Durobolic Injection by Asia Pharma

Durabolin - Durobolic Injection by Asia Pharma ONE ORDER UNIT INCLUDES: 10 ml vial containing 1000 mg 1 ml CONTAINS: 100 mg/ml TOTAL ml PER ONE ORDER...
EUR 79.00



DURABOLIN 100 mg - DUROBOLIC INJECTION by Asia Pharma - 3 Vials

DURABOLIN 100 mg - DUROBOLIC INJECTION by Asia Pharma - 3 Vials

DURABOLIN - DUROBOLIC INJECTION by Asia Pharma - 3 Vials ONE ORDER UNIT INCLUDES: 3 Vials of Durobolic Injection by Asia Pharma, 10 ml Vial...
EUR 237.00
EUR 189.00
Save: 20% off



Durabolin 100 mg - Nandone PE Injection by Casablanca Pharma

Durabolin 100 mg - Nandone PE Injection by Casablanca Pharma

Durabolin - Nandone PE Injection by Casablanca Pharmaceuticals ONE ORDER UNIT INCLUDES: 2 ml vial containing 200 mg 1 ml CONTAINS: 100 mg/ml TOTAL ml...
EUR 19.00




Nandrolone Phenylpropionate Profile:

Nandrolone Phenylpropionate is an injectable form of the anabolic steroid Nandrolone. The properties of this drug are strikingly similar to those of Deca-Durabolin, which uses the slower acting drug Nandrolone Decanoate. The primary difference between these two preparations is the speed in which Nandrolone is released into the blood. While Nandrolone Decanoate provides a release of Nandrolone from the area of injection lasting approximately 3 weeks, Nandrolone Phenylpropionate is active for only about a week. In clinical situations, Deca Durabolin can thus be injected once every 2 or 3 weeks, while Durabolin is usually administered every several days to once weekly. Otherwise, the two drugs are virtually interchangeable. Like Deca-Durabolin, Durabolin is valued by athletes and bodybuilders for its abilities to promote strength and lean muscle mass gains without significant estrogenic or androgenic side effects.

Nandrolone Phenylpropionate was first described in 1957. Durabolin became a prescription medication shortly after, sold by the international pharmaceuticals giant Organon under the brand name Durabolin. When Durabolin was first introduced to the United States, indicated uses of Nandrolone Phenylpropionate included pre-and postoperative lean mass retention, osteoporosis, advanced breast cancer, weight loss due to convalescence or disease, geriatric states (general weakness and frailty), burns, severe trauma, ulcers, adjunct therapy with certain forms of anemia, and selective cases of growth and development retardation in children. During the 1970's, the FDA began revising the indicated uses of this drug, however, and they were soon significantly narrowed. Moving forward, the drug was mainly being indicated for the treatment of advanced metastatic breast cancer, and as adjunct therapy for the treatment of senile and post-menopausal osteoporosis.

Durabolin was a key focus of Organon's marketing efforts of only for well less than a decade following its release. Once Deca-Durabolin was introduced during the 1960's, this shorter-acting counterpart, although still available, started to take a back seat. Durabolin was not completely abandoned by Organon, however, partly due to the fact that it was given a slightly different set of therapeutic uses in certain countries, and therefore continued to hold onto a niche market. As the size of the anabolic steroid market continued to grow throughout the 1970's and '80's, it was Nandrolone Decanoate that was attracting the most attention of other drug manufacturers. Numerous drug companies had produced their own versions of Nandrolone Phenylpropionate over the years, however,and the drug remains fairly available today. Organon continues to sell its original brand of Durabolin as well, but only in select markets, most notably Portugal, India, Malaysia, Indonesia, Netherlands, Finland, and Taiwan.

Nandrolone Phenylpropionate is available in select human drug markets. Composition and dosage may vary by country and manufacturer, but usually contain 25 mg/mL or 50 mg/mL of steroid dissolved in oil.

Nandrolone Phenylpropionate is a modified form of Nandrolone, where a carboxylic acid ester (propionilphenyl ester) has been attached to the 17-beta hydroxy group. Esterified steroids are less polar than free steroids, and are absorbed more slowly from the area of injections. Once in the bloodstream, the ester is removed to yield freely (active) Nandrolone. Esterified steroids are designed. to prolong the window of therapeutic effect following administration, allowing for a less frequent injections schedule compared to injections of free (unesterified) steroid. Nandrolone Phenylpropionate provides a sharp spike in Nandrolone release 24-48 hours following deep intramuscular injection, and declines to near baseline: levels within a week.

Nandrolone has a low tendency for estrogen conversion, estimated to be only about 20% of that seen with Testosterone. This is because while the liver can convert Nandrolone to Estradiol, in other more active sites of steroid aromatization such as adipose tissue Nandrolone is far less open to this process. Consequently, estrogen related side effects are a much lower concern with this drug than with Testosterone. Elevated estrogen levels may still be noticed with higher dosing, however, and may cause side effects such as increased water retention, body fat gain, and gynecomastia. An anti-estrogen such as Clomid (Clomiphene Citrate) or Tamoxifen Citrate may be necessary to prevent estrogenic side effects if they occur. One may alternately use an aromatase inhibitor like Arimidex (Anastrozole), which more efficiently controls estrogen by preventing its synthesis. Aromatase inhibitors can be quite expensive in comparison to anti-estrogens, however, and may also have negative effects on blood lipids.

It is of note that Nandrolone has some activity as a progestin in the body. Although progesterone is a c-19 steroid, removal of this group as in 19-norprogesterone creates a hormone with greater binding affinity for its corresponding receptor. Sharing this trait, many 19-nor anabolic steroids are shown to have some affinity for the progesterone receptor as wel1. The side effects associated with progesterone are similar to those of estrogen, including negative feedback inhibition of Testosterone production and enhanced rate of fat storage. Progestins also augment the stimulatory effect of estrogens on mammary tissue growth. There appears to be a strong synergy between these two hormones here, such that gynecomastia might even occur with the help of progestins, without excessive estrogen levels. The use of an anti-estrogen, which inhibits the estrogenic component of this disorder, is often sufficient to mitigate gynecomastia caused by Nandrolone.

Although classified as an anabolic steroid, androgenic side effects are still possible with this substance, especially with higher doses. This may include bouts of oily skin, acne, and body/facial hair growth. Anabolic/androgenic steroids may also aggravate male pattern hair loss. Women are warned of the potential virilizing effects of anabolic/androgenic steroids. These may include a jeepening of the voice, menstrual irregularities, changes n skin texture, facial hair growth, and clitoral enlargement. Nandrolone is a steroid with relatively low lndrogenic activity relative to its tissue-building actions, naking the threshold for strong androgenic side effects omparably higher than with more androgenic agents such as Testosterone, Methandrostenolone, or Fluoxymesterone. It is also important to point out that due to its mild androgenic nature and ability to suppress endogenous Testosterone, Nandrolone is prone to interfering with libido in males when used without another androgen.

Note that in androgen-responsive target tissues such as the skin, scalp, and prostate, the relative androgenicity of Nandrolone is reduced by its reduction to dihydronandrolone (DHN). The S-alpha. reductase enzyme is responsible for this metabolism of Nandrolone. The concurrent use of a 5-alpha reductase inhibitor such as Finasteride or Dutasteride will interfere with sites pecific reduction of Nandrolone action, considerably increasing the tendency of Nandrolone to produce androgenic side effects. Reductase inhibitors should be avoided with Nandrolone if low androgenicity is desired.

Nandrolone is not c-17 alpha alkylated, and not known to have hepatotoxic effects. Liver toxicity is unlikely.

Anabolic/androgenic steroids can have deleterious effects on serum cholesterol. This includes a tendency to reduce HDL (good) cholesterol values and increase LDL (bad) cholesterol values, which may shift the HDL to LDL balance in a direction that favors greater risk of arteriosclerosis. The relative impact of an anabolic/androgenic steroid on serum lipids is dependant on the dose, route of administration (oral vs. injectable), type of steroid (aromatizable or non-aromatizable), and level of resistance to hepatic metabolism. Studies administering 600 mg of Nandrolone Decanoate per week for 10 weeks demonstrated a 26% reduction in HDL cholesterol levels. This suppression is slightly greater than that reported with an equal dose of Testosterone enanthate, and is in agreement with earlier studies showing a slightly stronger negative impact on HDL/LDL ratio with Nandrolone Decanoate as compared to Testosterone Cypionate. Nandrolone should still have a significantly weaker impact on serum lipids than c-17 alpha alkylated agents. Anabolic/androgenic steroids may also adversely effect blood pressure and triglycerides, reduce endothelial relaxation, and support left ventricular hypertrophy, all potentially increasing the risk of cardiovascular disease and myocardial infarction.

To help reduce cardiovascular strain it is advised to maintain an active cardiovascular exercise program and minimize the intake of saturated fats, cholesterol, and simple carbohydrates at all times during active AAS administration. Supplementing with fish oils (4 grams per day) and a natural cholesterol/antioxidant formula such as Lipid Stabil or a product with comparable ingredients is also recommended.

All anabolic/androgenic steroids when taken in doses sufficient to promote muscle gain are expected to suppress endogenous Testosterone production. Studies administering 100 mg injection of Nandrolone Phenylpropionate demonstrated a rapid suppression of serum Testosterone following a single injection. Testosterone levels declined to approximately 30% of initial level by day 3 after drug administration, and stayed suppressed for approximately 13 days. Regular use is expected to significantly lengthen the endogenous hormone recovery window. It is believed that the progestational activity of Nandrolone notably contributes to the suppression of Testosterone synthesis during therapy, which can be marked in spite of a low tendency for estrogen conversion. Without the intervention of Testosterone-stimulating substances, Testosterone levels should return to normal within 2-6 months of drug secession. Note that prolonged hypogonadotrophic hypogonadism can develop secondary to steroid abuse, necessitating medical intervention.

The above side effects are not inclusive.

For general anabolic effects, early prescribing guidelines recommend a Durabolin dosage for man of 25-50 mg per week for 12 weeks. The usual dosage for physique-or performance enhancing purposes is in the range of 200-400 mg per week, taken in cycles 8 to 12 weeks in length. This level is sufficient for most users to notice measurable gains in lean muscle mass and strength. Note that due to the fastacting nature of the Phenylpropionate ester, the weekly dosage is usually subdivided into 2 separate applications spaced evenly apart.

For general anabolic effects, early prescribing guidelines recommend a dosage for woman of 25-50 mg of Durabolin per week for 12 weeks. When used for physique-or performance-enhancing purposes, a dosage of 50 mg per week (given in a single weekly Durabolin injection) is most common, taken for cycle lasting 4 to 6 weeks. Higher doses or longer durations of use are discouraged due to potential for androgenic side effects. Although only slightly androgenic, women are occasionally confronted with virilization symptoms when taking this compound. Should virilizing side effects become a concern, Nandrolone Phenylpropionate should be discontinued immediately to help prevent a permanent appearance.

Featured Products - Male Hormones Injection


Monthly Specials For February


Copyright © 2018 EuroBolic.info